Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study ; volume:20 ; number:1 ; day:11 ; month:11 ; year:2021 ; pages:1-7 ; date:12.2021
Annals of clinical microbiology and antimicrobials ; 20, Heft 1 (11.11.2021), 1-7, 12.2021
- Creator
-
Chan, Shirley Chiu Wai
Chung, Ho Yin
Lau, Chak Sing
Li, Philip Hei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12941-021-00483-2
- URN
-
urn:nbn:de:101:1-2022012306511351678119
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chan, Shirley Chiu Wai
- Chung, Ho Yin
- Lau, Chak Sing
- Li, Philip Hei
- SpringerLink (Online service)
Other Objects (12)
Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole
Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
Pneumocystis jirovecii pneumonia: a case report
Lymphocyte apoptosis in murine Pneumocystis pneumonia
Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab
Infection image: cystic pneumocystis jirovecii pneumonia – forgotten?
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality
Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome
Reversed halo sign in pneumocystis pneumonia: a case report
Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole
Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
Pneumocystis jirovecii pneumonia: a case report
Lymphocyte apoptosis in murine Pneumocystis pneumonia
Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab
Infection image: cystic pneumocystis jirovecii pneumonia – forgotten?
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality
Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome
Reversed halo sign in pneumocystis pneumonia: a case report
Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole
Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
Pneumocystis jirovecii pneumonia: a case report
Lymphocyte apoptosis in murine Pneumocystis pneumonia
Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab
Infection image: cystic pneumocystis jirovecii pneumonia – forgotten?
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality
Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome